TAU research identifies antibodies that may make coronavirus vaccines unnecessary

A team of researchers from Tel Aviv University (TAU) has demonstrated that antibodies isolated from the immune system of recovered COVID-19 patients are effective in neutralizing all known strains of the virus, including the Delta and the Omicron variants. According to the researchers, this discovery may eliminate the need for repeated booster vaccinations and strengthen… Read More

Hyperbaric oxygen treatment effective in treating long-term COVID-19 symptoms

A new study from Tel Aviv University (TAU) found a promising treatment for long-term COVID-19 symptoms based on advanced Hyperbaric Oxygen Therapy (HBOT). The study is the first randomized controlled trial to demonstrate a real solution for long COVID. Patients exposed to an intensive protocol of HBOT treatments showed significant improvement compared to a control… Read More

Fourth dose of COVID-19 vaccine reduces risk of death in the elderly by 72%

A new study by Tel Aviv University (TAU) and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that a fourth dose of the existing COVID-19 vaccine is effective in protecting the elderly population in long-term care facilities from the Omicron variant. The research was based on a… Read More

COVID-19 variants originate in immunocompromised patients, TAU researchers say

A new Tel Aviv University (TAU) study reveals that many SARS-CoV-2 variants are likely formed in chronic COVID-19 patients who suffer from immunosuppression. The researchers suggest that a weakened antibody response, particular in the lower airways of these chronic patients, may prevent full recovery from the virus and drive the virus to mutate many times… Read More

Technology from TAU will use smart sensors to ensure vaccine safety

A new study from Tel Aviv University (TAU) enables vaccine developers to determine vaccine safety via smart wearable sensors that measure objective physiological parameters. According to the researchers, most clinical trials testing the safety of new vaccines. including COVID-19 vaccines, rely on participants’ subjective reports, which can lead to biased results. In contrast, objective physiological… Read More

TAU researchers develop dietary supplement to provide protection against COVID-19

Experts from Tel Aviv University (TAU) have shown that a new combination of common dietary supplements can provide protection against the COVID-19 virus as well as several common winter illnesses. The study was led by Professor Ehud Gazit, Professor Eran Bacharach, and Professor Daniel Segal of the Shmunis School of Biomedicine and Cancer Research at… Read More

The Covid-19 Vaccine Revolution

TAU Professor Jonathan Gershoni tells the story of the significant scientific landmarks that led to the creation of RNA vaccines, that are significant in the global battle against the pandemic.